Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Geron Corporation 

230 Constitution Drive

Menlo Park  California  94025  U.S.A.
Phone: 650-473-7700 Fax: 650-473-7750




Intergen Company 

 Company News
Geron Corporation (GERN) Signs Top Drug Over To Johnson & Johnson (JNJ) In Deal Worth $935 Million 11/14/2014 5:54:20 AM
Geron Corporation (GERN) Announces Presentations At American Society of Hematology Annual Meeting 11/6/2014 1:09:00 PM
Geron Corporation (GERN) Soars As The FDA Removes Full Clinical Hold On Imetelstat 11/3/2014 6:47:55 AM
Geron Corporation (GERN) Reports Second Quarter 2014 Financial Results 8/11/2014 3:27:56 PM
Geron Corporation (GERN) To Assume Sponsorship Of Myelofibrosis IST And IND 8/5/2014 9:10:40 AM
Geron Corporation (GERN) Announces Conference Call To Discuss Second Quarter 2014 Financial Results 7/30/2014 9:19:10 AM
Geron Corporation (GERN) Jumps As FDA Lifts Partial Hold On Myelofibrosis IST 6/12/2014 7:01:29 AM
Geron Corporation (GERN) Analyst Report: High Potential High Risk Biopharmaceutical Firm Seeking To Advance Novel Innovative Cancer Treatment For Myeloid Malignancies By BrokerBank Securities, Inc. 4/7/2014 9:47:36 AM
Geron Corporation (GERN) Says FDA Halts Patient Enrollment In Another Cancer Trial 3/20/2014 7:29:54 AM
Geron Corporation (GERN) Tanks As FDA Halts Development Of Blood Disorder Drug 3/12/2014 7:35:27 AM